| Identification | Back Directory | [Name]
Benzo[b]thiophene-3-carboxamide, 2-[(cyclobutylcarbonyl)amino]-4,5,6,7-tetrahydro- | [CAS]
612829-80-8 | [Synonyms]
WAY-345989
WAY 345989,WAY345989
2-(Cyclobutanecarboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide
Benzo[b]thiophene-3-carboxamide, 2-[(cyclobutylcarbonyl)amino]-4,5,6,7-tetrahydro- | [Molecular Formula]
C14H18N2O2S | [MOL File]
612829-80-8.mol | [Molecular Weight]
278.37 |
| Chemical Properties | Back Directory | [Boiling point ]
475.6±45.0 °C(Predicted) | [density ]
1.360±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
DMSO: 56 mg/mL (201.17 mM);Ethanol: 7 mg/mL (25.15 mM) | [form ]
Solid | [pka]
14.02±0.20(Predicted) | [color ]
White to off-white | [Water Solubility ]
Water: Insoluble |
| Hazard Information | Back Directory | [Uses]
Protein kinase G inhibitor-2 (Compound 266) is a mycobacterial protein kinase G inhibitor, with an IC50 of 3 μM. Protein kinase G inhibitor-2 can be used for mycobacterial infection research[1]. | [References]
[1] Missio Andrea, et al. 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and methods for medical intervention against mycobacterial infections. Patent. US20040171603. 2003-10-16. |
|
| Company Name: |
Bide Pharmatech Ltd.
|
| Telephone: |
400-1647117 13681763483 |
| Website: |
https://www.bidepharm.com/ |
|